"Where Everyone Has an MBA"
Tel: (612) 246-4616
Frequently Asked Questions
- Frequently Asked Questions
- User Testimonials
Halozyme Therapeutics, Inc. - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Halozyme Therapeutics, Inc.
Should You Consider Investing in Halozyme Therapeutics (HALO)?
- Oct 3rd, 2022 5:06 pm
We Ran A Stock Scan For Earnings Growth And Halozyme Therapeutics (NASDAQ:HALO) Passed With Ease
- Sep 21st, 2022 2:43 pm
Halozyme Therapeutics (HALO) Down 10.6% Since Last Earnings Report: Can It Rebound?
- Sep 8th, 2022 3:30 pm
Halozyme to Participate in the 2022 Wells Fargo Healthcare Conference
- Sep 1st, 2022 12:30 pm
Halozyme Therapeutics, Inc. Announces Upsize and Pricing of Private Offering of $625 Million of Convertible Senior Notes due 2028
- Aug 16th, 2022 2:32 am
Halozyme Therapeutics, Inc. Announces Proposed Offering of $500 Million of Convertible Senior Notes due 2028
- Aug 15th, 2022 11:00 am
Halozyme (HALO) Q2 Earnings and Sales Beat, Ups '22 Outlook
- Aug 10th, 2022 7:13 pm
Halozyme Therapeutics Shares Jump On Better Than Expected Annual Guidance
- Aug 10th, 2022 11:48 am
Halozyme Therapeutics (HALO) Q2 Earnings and Revenues Beat Estimates
- Aug 9th, 2022 10:15 pm
HALOZYME REPORTS SECOND QUARTER 2022 FINANCIAL AND OPERATING RESULTS
- Aug 9th, 2022 8:01 pm
Positive Results Announced from Phase III IMscin001 Study Evaluating Subcutaneous Formulation of Tecentriq® with ENHANZE® in Advanced Non-Small Cell Lung Cancer
- Aug 2nd, 2022 4:55 am
Halozyme to Report Second Quarter 2022 Financial and Operating Results
- Jul 26th, 2022 12:30 pm
Halozyme Therapeutics (NASDAQ:HALO) delivers shareholders solid 31% CAGR over 5 years, surging 6.7% in the last week alone
- Jul 13th, 2022 1:14 pm
Halozyme Therapeutics (HALO) Moves 7.3% Higher: Will This Strength Last?
- Jul 8th, 2022 11:22 am
Dow Jones Futures Fall After Techs Lead Stock Market Rebound; Investors See End To Fed Rate Hikes
- Jul 6th, 2022 12:08 pm
Does Halozyme Therapeutics, My Q2 Pick, Still Have a HALO Over It?
- Jul 1st, 2022 5:13 pm
7 Biotech Stocks With Key Catalysts Coming in July
- Jun 27th, 2022 10:15 am
Halozyme's (HALO) ENHANZE Drives Stock: Rally to Continue?
- Jun 21st, 2022 1:13 pm
Halozyme Therapeutics (HALO) Up 19.8% Since Last Earnings Report: Can It Continue?
- Jun 9th, 2022 3:30 pm
Halozyme to Participate in the Goldman Sachs 43rd Annual Global Healthcare Conference
- Jun 8th, 2022 12:30 pm
Frequently Asked Questions
Terms and Conditions
Copyright © 2022 VentureLine
Website developed by Digital Solutions